Clinical Trials on Multiple+Endocrine+Neoplasia+Type+2b
Total 59231 results
-
Altor BioScienceNational Cancer Institute (NCI)TerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
Zhujiang HospitalThe Third Affiliated Hospital of Southern Medical University; Sun Yat-Sen Memorial... and other collaboratorsTerminatedRelapsed/Refractory Multiple Myeloma(MM)China
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbHActive, not recruitingPreviously Untreated Symptomatic Multiple MyelomaGermany
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
TakedaCompleted
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
National Cancer Institute (NCI)CompletedMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
TakedaWithdrawn
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma
-
The First Affiliated Hospital with Nanjing Medical...UnknownRelapsed or Refractory Multiple MyelomaChina
-
Sun Yat-sen UniversityChina Food and Drug AdministrationWithdrawnRelapse/Refractory Multiple MyelomaChina
-
Gilead SciencesTerminated
-
Altor BioScienceNational Cancer Institute (NCI)UnknownRelapsed or Refractory Multiple MyelomaUnited States
-
University Hospital TuebingenCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Washington University School of MedicineGenzyme, a Sanofi CompanyCompletedRelapsed Or Refractory Multiple MyelomaUnited States
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
University Hospital, CaenLaphalCompleted
-
Assistance Publique - Hôpitaux de ParisUnknownFecal Microbiota | Digestive Neuroendocrine Tumor | Bacterial Signature
-
Arcispedale Santa Maria Nuova-IRCCSCompletedGastric Cancer | Lung Cancer | Mesothelioma | Pancreas CancerItaly
-
Universitaire Ziekenhuizen KU LeuvenCompletedOvarian Cancer | Peritoneal MetastasisBelgium
-
Hospices Civils de LyonUnknownSmall Intestine Cancer | Neuro-endocrine TumorsFrance
-
AbbottDatamap; ClinIntel; Catalent; NuvisanWithdrawnExocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2Germany, Spain
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cambridge University Hospitals NHS Foundation... and other collaboratorsCompletedOvarian Cancer | Peritoneal MetastasesUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedEpithelial Ovarian CancerFrance
-
IRCCS San RaffaeleRecruitingNeuroendocrine Tumors | Pancreatitis | Cancer of Pancreas | Pancreas NeoplasmItaly
-
Istituto Ortopedico RizzoliCompletedOsteogenesis Imperfecta | Multiple Osteochondroma | Ollier Disease | Maffucci SyndromeItaly
-
Helsinki University Central HospitalUniversity of Helsinki; Tampere University; Tampere University Hospital; Finnish...Active, not recruitingPrimary Aldosteronism | Pheochromocytoma | Adrenal Cushing Syndrome | Endocrine NeoplasiaFinland
-
Zhejiang UniversityNot yet recruitingLymph Node Metastases
-
University Medical Center GroningenErasmus Medical CenterCompletedPapillary Thyroid Cancer | Lymph Node MetastasesNetherlands
-
University of OklahomaRecruitingExocrine Pancreatic CancerUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, United States, Australia
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
PETHEMA FoundationRecruitingMultiple Myeloma in RelapseSpain
-
Beijing Mabworks Biotech Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Australia, Denmark, Sweden, Brazil, China, Spain, Czechia, Turkey, Poland, Netherlands, Argentina, Canada, United Kingdom, Greece, India
-
OriCell Therapeutics Co., Ltd.RecruitingRelapsed and/or Refractory Multiple MyelomaChina
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed and/or Refractory Multiple MyelomaChina
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Wuhan Union Hospital, ChinaWuhan Si'an Medical Technology Co., LtdRecruitingCS1+ or BCMA+ Multiple MyelomaChina
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia